The RSUs vest over four years, with 25% of the shares vesting on each anniversary of the grant date, subject to the new employee’s continued service relationship with Travere through the applicable ...
Detailed price information for Addus Homecare Corp (ADUS-Q) from The Globe and Mail including charting and trades.
Detailed price information for Jazz Pharma Plc (JAZZ-Q) from The Globe and Mail including charting and trades.
Travere Therapeutics (NASDAQ: TVTX) is attempting to change the pattern via which rare kidney diseases are treated. The ...
Investor's Business Daily on MSN
Travere crashed into its 200-day line and then reversed higher; here's why
Shares of Travere Therapeutics took a hit Tuesday, but closed in the green, after fewer than expected patients started taking ...
Travere Therapeutics, Inc. (Nasdaq: TVTX) today announced that company management will participate in the following upcoming investor conferences: Guggenheim Global Healthcare Conference Presenting on ...
Travere Therapeutics has delivered a very large 3 year share price gain, which naturally puts the spotlight on whether the current valuation can be explained by its sales base. With the stock around ...
Management reiterated the long-term FILSPARI goal rather than issuing quarterly EPS or revenue guidance: Dr. Dube said results and demand trends “are aligned with our long-term goals of achieving $3 ...
Q3 earnings swing to loss as revenue rises Travere Therapeutics (TVTX) just delivered third quarter 2026 numbers that pulled ...
Travere Therapeutics (NasdaqGM: TVTX) reported new biomarker data from the Phase 3 PROTECT Study of FILSPARI in IgA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results